 REDWOOD CITY, CA ACCESSWIRE June 26, 2020 Avinger, Inc. AVGR, a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease PAD, today announced the closing of an underwritten public offering of 20,000,000 shares of its common stock at a price of 0.27 per share, for total gross proceeds of approximately 5.4 million, before deducting underwriting discounts, commissions and other offering expenses payable by the Company. Additionally, the Company has granted the underwriters a 45-day option to purchase up to 15 additional shares of common stock to cover over-allotments, if any. The shares were offered pursuant to a registration statement on Form S-1 File No. 333-239177 previously filed with the Securities and Exchange Commission SEC, and a related registration statement on Form S-1 File No. 333-239398 filed pursuant to rule 462b of the Securities Act of 1933, which registration statements were declared effective by the SEC. 